Status:
COMPLETED
The Effect of Luteal Blood Progesterone Levels on Ongoing Pregnancy Rates
Lead Sponsor:
Hacettepe University
Collaborating Sponsors:
Anatolia IVF and Women's Health Center
Conditions:
Luteal Phase Progesterone Levels
Eligibility:
FEMALE
Up to 40 years
Phase:
NA
Brief Summary
Progesterone (P4) is essential for the secretory development of endometrium and the maintenance of early pregnancy. In the luteal phase following controlled ovarian stimulation in in vitro fertilizati...
Detailed Description
During Covid-19 pandemic we decided to make an interim analysis in March 2020. Since the shut down of the IVF clinics due to Covid-19 pandemic was over, we restarted our routine IVF practice and henc...
Eligibility Criteria
Inclusion
- Cycles induced with GnRH agonist or GnRH antagonist protocol
- BMI\<35 kg/m
- Retrieval of 3 or more metaphase II oocytes, irrespective of ovarian reserve testing
Exclusion
- Cycles triggered with GnRH agonist or dual trigger
- Circulating progesterone \> 1.5ng/mL on the day of trigger
- Cleavage stage embryo transfer
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 11 2022
Estimated Enrollment :
340 Patients enrolled
Trial Details
Trial ID
NCT04128436
Start Date
January 1 2019
End Date
August 11 2022
Last Update
August 15 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Androfert
Campinas, São Paulo, Brazil, 13075-460
2
Aarhus University
Aarhus, Denmark
3
Hacettepe University School of Medicine, Department of Ob/Gyn
Ankara, Turkey (Türkiye), 06100